1Gold P, Freedman SO. Demonstration of tumor specific antigen in human colonic carcinoma by immunologic tolerance and seption tech- niques[J]. Exp Meal,1965,12(7) :439-442.
2Okada M,Sakamoto T,Nishio W,et 8]. Characteristics and progno- sis of patients after resection of non small cell lung carcinoma measuring 2 cm or less in greatest dimension E J ]. Cancer,2003,98 ( 3 ) : 535-541.
3Higashi K, Sakuma T, Ito K, et al. Combined evaluation of preop- eractive FDG uptake on PET, gxound-glass opacity area on CT, and serum CEA level:identification of both low and high risk of recurrence in pa- tients with resected T1 lung adenocarcinoma[ J]. Eur Nucl Med Mol Ima- ging,2009,36(3) :373-381.
4Salsi V,Ferrari S,Ferrarosi R,et al. HOXD13 binds DNA replica- tion origins to promote origin licensing and is inhibited by geminin [ J ]. Mol Cell Biol,2009,29(21 ) :5775-5788.
5Lou E,Johnson ML, Sima C,et al. Analysis of a panel of serum bio- markers in patients with metastatic lung cancer[ J]. J Clln Oncol,2010,28 (15) :180-184.
6Molina R, AugeJM, EscuderoJM, etal. MucinsCA125, CA19-9, CA15-3 and TAG 72-3 as tumormarkers in patients with lung cancer: comparison with CYFBA 21-1, CEA, SCC-Ag and NSE[J]. Tumor Bin, 2008, 29(6): 371-380.
7Holdenrieder S, van Pawel J, Dankelmann E, et -1. Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in monitoring first-linchemother- apy of small cell lung cancer [ J ]. Clin Cancer Res, 2008, 14 ( 23 ) : 7813-7821.
8Koshiiahi H, Sakamoto K, Yasuraoka T, et al. Two resected cases of pulmonary adenocareinoma with intralober metastasis diagnosed by the pathological digmsis during the operation [ J ]. Gan To Kagaku Ryoho, 2010,37 (12) :2735-2737.
9Ando S, Kimura H, Iwai N, et al. Optimal combination of seven tumor markers in prediction of advanced stage at u, st examination of pa- tients with non-small cell lung cancer [ J ]. Anticancer Res, 2001,21 (46) :3085-3092.
10Shitrit D,Zingerman B, Shitrit AB, et al. Diagnostic value of CY- FRA21-1, CEA, CA19-9, CA15-3, and CA125 assays in pleuraleffusions: analysis of 116 cases and review of the literature[ J]. Oncologist,2005,10 (7) :501-507.
6Yang L,Yang G,Zhou M,et al.Body mass index and mortality from lung cancer in smokers and nonsmokers:A nationally representative prospective study of 220,000 men in China[J].Int J Cancer,2009,125 (9):2136-2143.
7Tan S,Sun C,Wei X,et al.Quantitative assessment of lung cancer associated with genes methylation in the peripheral blood[J].Exp Lung Res,2013,39(4-5):182-190.
8Van der Drift MA,Hol BE,Klaassen CH,et al.Circulating DNA is a non-invasive prognostic factor for survival in non-small cell lung cancer[J].Lung Cancer,2010,68 (2):283-287.
9Sirera R,Bremnes RM,Cabrera A,et al.Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer[J].J Thorac Oncol,2011,6 (2):286-290.
